Vanguard Group’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$13.3M Buy
6,028,179
+4,107,032
+214% +$6.61M ﹤0.01% 2817
2025
Q3
$3.05M Buy
1,921,147
+812,361
+73% +$1.05M ﹤0.01% 3432
2025
Q2
$1.8M Sell
1,108,786
-191,096
-15% -$309K ﹤0.01% 3570
2025
Q1
$1.55M Sell
1,299,882
-14,797
-1% -$23.6K ﹤0.01% 3578
2024
Q4
$2.71M Buy
1,314,679
+792,770
+152% +$1.85M ﹤0.01% 3476
2024
Q3
$1.32M Buy
521,909
+179,587
+52% +$586K ﹤0.01% 3686
2024
Q2
$1.46M Buy
342,322
+168,918
+97% +$1.09M ﹤0.01% 3667
2024
Q1
$1.28M Buy
+173,404
New +$1.46M ﹤0.01% 3731

Other funds holding GUTS

Vanguard Group's GUTS Position: Q4 2025 in Review

Vanguard Group increased its Fractyl Health (GUTS) stake by 214% in Q4 2025, buying an estimated $6.61M and bringing the position to 6,028,179 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

Vanguard Group first reported a position in GUTS in Q1 2024 and has held it in 8 quarters since. 97 funds tracked by Wall St. Rank hold GUTS as of Q4 2025.

  • Vanguard Group held 6,028,179 shares of Fractyl Health worth $13.3M as of Q4 2025.
  • Vanguard Group bought 4,107,032 Fractyl Health shares in Q4 2025, an estimated $6.61M.
  • Fractyl Health made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2817 holding.
  • Vanguard Group first reported a position in Fractyl Health in Q1 2024 and has held it in 8 quarters since.
  • 97 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.